Market revenue in 2023 | USD 21,710.5 million |
Market revenue in 2030 | USD 50,493.7 million |
Growth rate | 12.8% (CAGR from 2023 to 2030) |
Largest segment | Medical devices |
Fastest growing segment | Medical Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Medical Devices, Pharmaceutical |
Key market players worldwide | Nordson Corp, Integer Holdings Corp, Jabil Inc, Viant Technology Inc Ordinary Shares - Class A, Flex Ltd, Celestica Inc Ordinary Shares (Subordinate Voting), Sanmina Corp, Plexus Corp, Molex, West Pharmaceutical Services Inc, Catalent Inc, Thermo Fisher Scientific Inc, Recipharm, Boehringer Ingelheim, Lonza Group Ltd, Samsung BioLogics, Wuxi AppTec Co Ltd, FUJIFILM Holdings Corp, Cambrex |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract manufacturing market will help companies and investors design strategic landscapes.
Medical devices was the largest segment with a revenue share of 52.04% in 2023. Horizon Databook has segmented the China healthcare contract manufacturing market based on medical devices, pharmaceutical covering the revenue growth of each sub-segment from 2018 to 2030.
In 2016, as part of Marketing Authorization Holder (MAH) system reforms, China FDA legalized contract manufacturing, thus allowing domestic biopharmaceutical & pharmaceutical companies’ access to contract manufacturers, which is anticipated to fuel the market growth.
In addition, presence of EMA- and/or FDA-approved facilities in the country is also anticipated to increase foreign investments. For instance, nearly 92 contract service organizations have headquarters in Jiangsu with 72% of the facilities having EMA and/or FDA approval.
Horizon Databook provides a detailed overview of country-level data and insights on the China healthcare contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into China healthcare contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account